Atlas Trials

A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDR

Clinical trial NCT02735369 · TERMINATED

Trial details

NCT number
NCT02735369
Sponsor
OcuCure Therapeutics, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Proliferative Diabetic Retinopathy (PDR)
Start date
2014-12-01
Primary completion
2016-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.